abagovomab 44
abciximab 40
abituzumab 25
abrilumab 25
actoxumab 21
adalimumab 22
aducanumab 16
afasevikumab 21
alacizumab_pegol 15
alemtuzumab 37
alirocumab 27
amatuximab 51
andecaliximab 28
anifrolumab 25
anrukinzumab 24
aprutumab 23
aprutumab_ixadotin 23
arcitumomab 29
ascrinvacumab 12
atezolizumab 17
atinumab 18
avelumab 16
basiliximab 46
bavituximab 47
begelomab 35
benralizumab 36
bevacizumab_beta 28
bezlotoxumab 21
bimagrumab 26
bleselumab 25
blinatumomab 42
blosozumab 34
bococizumab 22
brazikumab 20
brentuximab_vedotin 43
briakinumab 24
brodalumab 23
brolucizumab 31
brontictuzumab 30
burosumab 24
cabiralizumab 31
camrelizumab 16
canakinumab 29
cantuzumab_ravtansin 52
carlumab 18
carotuximab 32
cergutuzumab_amunaleukin2 35
cergutuzumab_amunaleukin 35
certolizumab_pegol 27
cetiximab 52
citatuzumab_bogatox 30
cixutumumab 36
clivatuzumab_tetraxetan 33
codrituzumab 35
conatumumab 19
concizumab 33
crenezumab 25
crizanlizumab 30
crotedumab 24
dacetuzumab 26
daclizumab 26
dalotuzumab 44
dapirolizumab_pegol 29
daratumumab 14
dectrekumab 11
demcizumab 35
denosumab 11
depatuxizumab 33
depatuxizumab_mafodotin 33
dezamizumab 26
dinutuximab 43
diridavumab 32
domagrozumab 18
drozitumab 29
duligotuzumab 21
durvalumab 15
dusigitumab 30
efalizumab 37
efungumab 34
eldelumab 19
elezanumab 25
elgemtumab 14
elotuzumab 21
emactuzumab 28
emapalumab 31
emibetuzumab 29
enavatuzumab 27
enfortumab_vedotin 15
enoblituzumab 23
enokizumab 28
enoticumab 23
ensituximab 45
eptinezumab 20
erenumab 30
etaracizumab 18
etrolizumab 25
evinacumab 24
evolocumab 28
farletuzumab 17
fasinumab 30
fezakinumab 33
fibatuzumab 22
ficlatuzumab 29
firivumab 39
flanvotumab 24
fletikumab 32
foralumab 17
foravirumab 17
fremanezumab 32
fresolimumab 20
fulranumab 24
futuximab 40
galcanezumab 25
ganitumab 34
gantenerumab 15
gemetuzumab 36
gemtuzumab2 28
gemtuzumab 36
gevokizumab 31
girentuximab 39
glembatumumab 26
glembatumumab_vedotin 26
guselkumab 28
ibalizumab 36
ibritumomab 47
icrucumab 14
idarucizumab 48
ifabotuzumab 22
imalumab 19
imgatuzumab 25
inclacumab 21
indatuximab_ravtansin 43
indusatumab 23
inebilizumab 34
intetumumab 19
iodine_girentuximab 31
ipilimumab 8
iratumumab 18
isatuximab 43
itolizumab 30
ixekizumab 38
labetuzumab_govitecan 32
lambrolizumab 32
lampalizumab 32
lanadelumab 19
landogrozumab 19
laprituximab 34
lebrikizumab 43
lendalizumab 28
lenzilumab 21
lifastuzumab_vedotin 26
ligelizumab 28
lilotomab 49
lirilumab 26
lodelcizumab 24
lokivetmab 28
lorvotuzumab_mertansin 30
lucatumumab 31
lumretuzumab 28
lupartumab 22
lutikizumab 23
margetuximab 46
milatuzumab 46
mirvetuximab 45
mirvetuximab_soravtansin 45
modotuximab 47
mogamulizumab 36
monalizumab 28
motavizumab 43
moxetumomab_pasudotox 36
namilumab 32
naratuximab 36
naratuximab_emtansin 36
narnatumab 21
navicixizumab2 33
navicixizumab 36
navivumab 41
necitumumab 12
nemolizumab 33
nesvacumab 18
nivolumab 16
obiltoxaximab 29
obinutuzumab 39
ocaratuzumab 29
ofatumumab 20
olaratumab 25
olokizumab 29
omalizumab 22
onartuzumab 25
ontuxizumab 38
opicinumab 15
orticumab 17
otelixizumab 42
oxelumab 14
ozanezumab 40
pamrevlumab 13
panobacumab 32
parsatuzumab 31
pasotuxizumab 23
pateclizumab 22
patritumab 32
pembrolizumab 32
perakizumab 25
pidilizumab 27
pinatuzumab_vedotin 19
plozalizumab 37
pogalizumab 28
polatuzumab_vedotin 24
ponezumab 42
prezalumab 17
pritoxaximab 48
quilizumab 23
racotumomab 39
radretumab 16
ralpancizumab 25
ramucirumab 14
ranevetmab 35
ranibizumab 28
refanezumab 31
remtolumab 22
rilotumumab 27
rinucumab 27
risankizumab 41
rituximab 34
rivabazumab 26
robatumumab 20
roledumab 38
romosozumab 31
rontalizumab 26
rosmantuzumab 32
rozanolixizumab 28
sacituzumab 35
sacituzumab_govitecan 35
samalizumab 32
sapelizumab 31
sarilumab 19
secukinumab 20
seribantumab 18
setoxaximab 53
sifalimumab 21
siltuximab 31
simtuzumab 31
sirukumab 15
solanezumab 28
solitomab 37
stamulumab 26
suptavumab 28
suvizumab 28
tabalumab 20
tadocizumab 22
tamtuvetmab 40
tanezumab 30
tarextumab 13
tavolixizumab 23
telisotuzumab 36
teplizumab 28
tesidolumab 30
tezepelumab 31
tigatuzumab 18
tildrakizumab 27
timolumab 18
tisotumab 16
tosatoxumab 50
tositumomab 46
tralokinumab 39
trastuzumab 25
tregalizumab 34
trevogrumab 16
ublituximab 40
urelumab 29
ustekinumab 30
utomilumab 32
vadastuximab 33
vadastuximab_talirin 33
vandortuzumab_vedotin 24
vantictumab 25
vanucizumab2 28
vanucizumab 39
varlilumab 19
vatelizumab 28
vedolizumab 33
veltuzumab 25
vesencumab 13
vorsetuzumab 32
vorsetuzumab_mafodotin 32
vunakizumab 44
xentuzumab 23
zatuximab 47
